Cargando…

Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival

PURPOSE: Iodine-125 ((125)I) brachytherapy (BT) alone for intermediate-risk (IR) prostate adenocarcinoma (PCA) is controversial. The purpose of the study was to investigate potential predictive factors in selected IR-PCA patients treated with BT. MATERIAL AND METHODS: Among 547 patients treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robin, Sophie, Chabaud, Sylvie, Serre, Anne-Agathe, Bringeon, Béatrice, Clippe, Sébastien, Rocher, François, Desmettre, Olivier, Bringeon, Gabriel, Gassa, Frédéric, Pommier, Pascal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2021
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8407263/ https://www.ncbi.nlm.nih.gov/pubmed/34484351 http://dx.doi.org/10.5114/jcb.2021.108592

Ejemplares similares

Permanent (125)I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence
por: Mazeron, Renaud, et al.
Publicado: (2012)

Combined intra-cavitary and interstitial image-guided adaptative brachytherapy for cervical stump carcinomas: technical and clinical results of six patients
por: Guillemin, Florent, et al.
Publicado: (2022)

Iodine-125 brachytherapy for brain tumours - a review
por: Schwarz, Silke B, et al.
Publicado: (2012)

A Robust Oxygen Microbubble Radiosensitizer for Iodine‐125 Brachytherapy
por: Peng, Sheng, et al.
Publicado: (2021)

Histopathology of Intraocular Medulloepithelioma following Iodine-125 Plaque Brachytherapy
por: Mohan, Sukriti, et al.
Publicado: (2022)

Effect of neoadjuvant iodine-125 brachytherapy upon resection of glioma
por: Wang, Congxiao, et al.
Publicado: (2022)

Salvage brachytherapy with or without external beam radiotherapy for oral or oropharyngeal squamous cell carcinomas in previously irradiated areas: carcinologic and toxicity outcomes of 25 patients
por: Pialat, Pierre-Marie, et al.
Publicado: (2021)

Experimental study of pelvic perioperative brachytherapy with iodine 125 seeds (I-125) in an animal model
por: Brun, Thomas, et al.
Publicado: (2018)

Regression patterns of uveal melanoma after iodine-125 plaque brachytherapy
por: Fang, Rui, et al.
Publicado: (2021)

Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM()
por: Kirisits, Christian, et al.
Publicado: (2014)

GEC ESTRO ACROP consensus recommendations for contact brachytherapy for rectal cancer
por: Stewart, Alexandra J., et al.
Publicado: (2021)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Treasure of the Past IX: Exposure Standardization of Iodine-125 Seeds Used for Brachytherapy
por: Loftus, T. P.
Publicado: (2001)

Value of CT-MRI fusion in iodine-125 brachytherapy for high-grade glioma
por: Gao, Yang, et al.
Publicado: (2017)

Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer
por: Du, E, et al.
Publicado: (2017)

Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
por: Leite, Elton Trigo Teixeira, et al.
Publicado: (2019)

Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Silicone Oil and Iodine-125 Brachytherapy for Uveal Melanoma in High-Risk Patients
por: Lyons, Lance J, et al.
Publicado: (2019)

Safety and efficacy of iodine-125 seed strand for intraluminal brachytherapy on ureteral carcinoma
por: Bi, Yonghua, et al.
Publicado: (2023)

SIOG (International Society of Geriatric Oncology) recommendations for anthracycline use in the elderly
por: Aapro, Matti
Publicado: (2011)

Measurement of the strength of iodine-125 seed moving at unknown speed during implantation in brachytherapy
por: Tanaka, Kenichi, et al.
Publicado: (2014)

Changes in lower urinary tract symptoms after iodine-125 brachytherapy for prostate cancer
por: Onishi, Kenta, et al.
Publicado: (2018)

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)

Correction to: Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
por: Wang, Congxiao, et al.
Publicado: (2020)

Intra-operative ocular ultrasonography of iodine-125 brachytherapy plaques in patients with uveal melanoma
por: Ces, Antonio Piñeiro, et al.
Publicado: (2021)

Iodine-(125) plaque brachytherapy for aggressive squamous cell carcinoma with corneal and scleral invasion
por: Kaufman, Aaron R., et al.
Publicado: (2022)

Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review
por: Zuber, Simon, et al.
Publicado: (2015)

Impact of Gleason Pattern 5 on outcomes of patients with prostate cancer and iodine-125 prostate brachytherapy
por: Makino, Tomoyuki, et al.
Publicado: (2016)

A novel auto‐positioning method in Iodine‐125 seed brachytherapy driven by preoperative planning
por: Ma, Xiaodong, et al.
Publicado: (2019)

Dosimetric differences between cesium-131 and iodine-125 brachytherapy for the treatment of resected brain metastases
por: Yondorf, Menachem Z., et al.
Publicado: (2020)

Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas
por: Hadi, Indrawati, et al.
Publicado: (2021)

CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
por: Dong, Hong, et al.
Publicado: (2021)

Three-dimensional template combined with MR-guided iodine-125 brachytherapy for recurrent brain metastases
por: He, Xiangmeng, et al.
Publicado: (2023)

CT-guided iodine-125 brachytherapy as salvage therapy for local-regional recurrent breast cancer
por: Wang, Juan, et al.
Publicado: (2023)

Adjuvant Iodine-125 Brachytherapy for Hepatocellular Carcinoma after Complete Hepatectomy: A Randomized Controlled Trial
por: Chen, Kaiyun, et al.
Publicado: (2013)

Iodine-125 prostate seed brachytherapy in renal transplant recipients: an analysis of oncological outcomes and toxicity profile
por: Beydoun, Nadine, et al.
Publicado: (2014)

Strength estimation of a moving (125)Iodine source during implantation in brachytherapy: application to linked sources
por: Tanaka, Kenichi, et al.
Publicado: (2014)

Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wu, Chunrong, et al.
Publicado: (2020)

Brachytherapy with Iodine-125 seeds for treatment of portal vein-branch tumor thrombus in patients with hepatocellular carcinoma
por: Hong, Duo, et al.
Publicado: (2021)

Dosimetric Evaluation and Clinical Application of Radioactive Iodine-125 Brachytherapy Stent in the Treatment of Malignant Esophageal Obstruction
por: Ji, Zhe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0ovurusctda1r24o87afmc018f